Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A model for the interim analysis process: a case study.

Leticia Delgado-Herrera¹, Dan Anbar

¹Abbott Laboratories, Abbott Park, IL 60064, USA. herrel@hpd.abbott.com

Controlled Clinical Trials

|February 1, 2003

Summary

Interim analyses allow early evaluation of clinical trial data but require careful execution. A pivotal trial for an autoimmune disease drug was terminated early following a second interim analysis, highlighting the importance of proper methodology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pudexacianinium (ASP5354) chloride for ureter visualization in participants undergoing laparoscopic, minimally invasive colorectal surgery.

Surgical endoscopy·2023

Same author

Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.

Therapeutic advances in gastroenterology·2017

Same author

Diarrhea-predominant irritable bowel syndrome: creation of an electronic version of a patient-reported outcome instrument by conversion from a pen-and-paper version and evaluation of their equivalence.

Patient related outcome measures·2017

Same author

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.

Clinical pharmacology in drug development·2016

Same author

Cultural adaptation: translatability assessment and linguistic validation of the patient-reported outcome instrument for irritable bowel syndrome with diarrhea.

Patient related outcome measures·2016

Same author

Psychometric assessment of the IBS-D Daily Symptom Diary and Symptom Event Log.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016

Area of Science:

Clinical trial methodology
Pharmaceutical drug development
Biostatistics

Background:

Interim analyses are crucial for evaluating ongoing clinical trials before completion.
Improperly conducted interim analyses can jeopardize clinical trial integrity.
Regulatory guidelines have evolved to permit sponsor access to unblinded data during trials.

Purpose of the Study:

To describe the planning, execution, and lessons learned from interim analyses in a pivotal Phase II/III clinical trial.
To discuss the methodology and roles involved in performing interim analyses for drug development.

Main Methods:

A pivotal Phase II/III clinical trial for an autoimmune disease drug involved two interim analyses.
The trial design incorporated interim analyses due to initial uncertainty regarding drug safety and efficacy.

Related Experiment Videos

Procedures for planning and executing interim analyses were followed.

Main Results:

The second interim analysis led to the early termination of the clinical trial.
The experience provided valuable lessons regarding the implementation of interim analyses.

Conclusions:

Careful planning and execution of interim analyses are essential to maintain clinical trial integrity.
Interim analyses can inform critical decisions, such as early trial termination.
Established methodologies and clear roles are vital for successful interim analysis.